The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis (Q57392760)

1

object named as

Amita Shukla-Dave

0 references

author name string

Michael W. Kattan

3

0 references

Darko Pucar

4

0 references

Kentaro Kuroiwa

5

0 references

Hui-Ni Chen

6

0 references

Jessica Spector

7

0 references

Jason A. Koutcher

8

0 references

Kristen L. Zakian

9

0 references

Peter T. Scardino

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

10

0 references

publication date

April 2007

0 references

published in

BJU International

0 references

volume

99

0 references

issue

4

0 references

page(s)

786-793

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Prospective evaluation of men with stage T1C adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Expectant management: an option for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X

Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.06689.X